Oren Livnat
Stock Analyst at HC Wainwright & Co.
(1.06)
# 1685
Out of 5,319 analysts
210
Total ratings
42.74%
Success rate
2.89%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
PCRX Pacira BioSciences | Maintains: Strong Buy | 48 65 | 24.65 | 163.69% | 20 | Apr 8, 2025 | |
VRCA Verrica Pharmaceutic... | Reiterates: Neutral | n/a | n/a | n/a | 12 | Apr 8, 2025 | |
COLL Collegium Pharmaceut... | Reiterates: Buy | 50 50 | 27.01 | 85.12% | 10 | Mar 24, 2025 | |
TRVI Trevi Therapeutics | Reiterates: Buy | 13 13 | 6.07 | 105.93% | 7 | Mar 19, 2025 | |
ANIP ANI Pharmaceuticals | Reiterates: Buy | 94 94 | 69.21 | 35.82% | 13 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 20 20 | 7.15 | 179.72% | 9 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 200 217 | 102.78 | 111.13% | 17 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Strong Buy | 7 8 | 4.11 | 94.65% | 11 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 21 21 | 8.03 | 161.52% | 16 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 73 73 | 49.25 | 48.22% | 9 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 12 12 | 2.09 | 474.16% | 1 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 12 12 | n/a | n/a | 2 | Sep 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 13 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 8 8 | 4.54 | 65.2% | 6 | Jan 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 12 | n/a | n/a | 9 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 6 | Apr 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 7 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 11 10 | n/a | n/a | 4 | Aug 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 24 17 | n/a | n/a | 6 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 4 | Aug 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 14 8 | 0.9 | 788.89% | 2 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 6 | n/a | n/a | 4 | Apr 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 4 5 | n/a | n/a | 5 | Jan 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 43 60 | 3 | 1883.33% | 5 | Aug 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 11 8 | n/a | n/a | 2 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 252 198 | 1.85 | 10602.7% | 2 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 4 3 | n/a | n/a | 6 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 13 | n/a | n/a | 2 | Oct 15, 2018 |